Effects of long-acting contraceptives on women's iron levels and responses to extreme environments

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study investigates how long-acting reversible contraceptives (LARCs) like implants and IUDs affect iron status and physiological responses in military women exposed to extreme environments such as heat, cold, and high altitude. It aims to determine if LARCs, which are known to reduce menstrual blood loss, can help preserve iron stores and potentially improve health and performance. Participants will undergo blood volume and environmental testing to assess these impacts. The study focuses on women aged 18-40 who have been using LARCs or oral contraceptives for at least a year.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* • Females, age 18-40 y

  * Females taking monophasic oral contraceptives or utilizing implantable contraception (intrauterine device, implantable bar) for at least one year, and be at least one year removed from the removal end point (e.g. before year 4 for a 5-year IUD)
  * In good health as determined by OMSO (Office of Medical Support and Oversight)
  * Passed most recent Army Combat Fitness Test (ACFT) (military volunteers only) or exercise at least 2 times per week (civilian volunteers)
  * Willing to not drink alcoholic beverages for 24 hours before each testing session
  * Willing to not consume caffeine 12 hours prior to any testing sessions
  * Willing to refrain from any exercise and additional moderate to strenuous physical activity 24 hours prior to testing
  * Willing to stay and exercise in an altitude chamber (the size of a dorm room) for \~6 hours
  * Supervisor approval for federal civilian employees and non-HRV active-duty military personnel stationed at NSSC.

Exclusion Criteria:

* • Females who are pregnant, planning to become pregnant during the study, or breastfeeding.

  * Taking prescription, over the counter medication, or dietary supplements, other than a contraceptive (unless approved by OMSO and Principal Investigator (PI))
  * Tobacco or nicotine users, or anyone who has used tobacco or nicotine within the last four months
  * Physical problems/injuries (e.g., current stress fractures, musculoskeletal strains) that would affect walking or running on a treadmill
  * Allergy to skin adhesive
  * Heart, lung, kidney, muscle, endocrine, or nerve disorder(s) as determined by OMSO
  * History of heat intolerance or orthostatic intolerance
  * Diagnosed and/or treated for fluid/electrolyte imbalance within the last 30 days
  * History of obstructive disease of the gastrointestinal tract including (but not limited to) diverticulosis, diverticulitis and inflammatory bowel disease, peptic ulcer disease, Crohn's disease, ulcerative colitis.
  * Scheduled MRI within 2 weeks after completing a heat or cold test
  * Actively dieting with the intent to lose weight
  * History of cold injuries of any severity (e.g., frostbite, trench foot, chilblains).
  * Raynaud's syndrome
  * Cold-induced asthma/bronchospasm
  * Not willing to have small areas of skin on the body shaved (if deemed necessary for attachment of study instrumentation)
  * Born at altitudes greater than 2,100 m (7,000 ft) (e.g., Mexico City, Mexico)
  * Living in areas that are more than 1,200 m (4,000 ft) (e.g., Colorado Springs, CO) or have traveled to areas that are more than 1,200 m for five days or more within the last 2 months
  * Prior diagnosis of High Altitude Pulmonary Edema (HAPE) or High Altitude Cerebral Edema (HACE)
  * Abnormal blood count in accordance with OMSO - Normal Hb women: 11.1-15.9 g·dL-1 or Normal Hct women: 34.0-48%, or presence of abnormal blood chemicals (hemoglobin S or Sickle Cell Trait)
  * History of pneumothorax
  * History of hypertension
  * Blood donation within 8 weeks of beginning the study
  * Any recent (within 4-6 weeks) and or expected history of prolonged periods of immobility or limited activity (including recent or upcoming surgery)
  * Evidence of apnea or sleeping disorder (narcolepsy, insomnia, etc.)

Where it's running

• US Army Research Institute of Environmental Medicine
  Natick, Massachusetts, United States Recruiting

Study contacts

• Principal investigator: Gabrielle Giersch, PhD — United States Army Research Institute of Environmental Medicine
• Study coordinator: Gabrielle E Giersch, PhD
• Email: gabrielle.e.giersch.civ@health.mil
• Phone: 508-206-2421

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Iron absorption from a hydrogel iron supplement with and without breakfast

  This study tests how well three low-dose hydrogel iron supplements are absorbed in non-anemic, iron-depleted women, compared with regular ferrous fumarate, using labeled iron to measure absorption.

  Recruiting ETH Zurich · Zurich, Canton of Zurich · NCT07921433

• Iron status at ICU discharge in adults with anemia after critical illness

  We are testing whether iron deficiency is common at ICU discharge and whether it relates to how well patients recover after leaving the ICU.

  Recruiting Università degli Studi di Ferrara · Brussels and 3 other locations · NCT07781540

• CTX001: a pill to help iron move where it’s needed in healthy adults

  This early test checks if CTX001 is safe and how it behaves in the body to help iron get into red blood cells in healthy adults, with or without iron and with or without food.

  Recruiting Early Phase 1 Cajal Therapeutics Inc. · Melbourne, Victoria · NCT07577817

• Effectiveness of the Natural Cycles birth control app

  This study will test how well the Natural Cycles app prevents pregnancy over one year in sexually active women aged 18 to 35 with no known infertility.

  Recruiting Natural Cycles · New York, New York · NCT07566793

• Sucrosomial iron for children with celiac disease and iron deficiency

  This trial tests whether adding oral Sucrosomial® (Sideral forte®) iron drops to a gluten-free diet helps children aged 8–18 with newly diagnosed celiac disease and low iron or anemia recover hemoglobin and iron stores faster than diet alone.

  Recruiting Istituto Giannina Gaslini · Genova, Italy · NCT07563582

• Lactoferrin with low-dose iron to boost iron levels and aerobic fitness in active women

  We will test whether taking lactoferrin with a small daily dose of iron helps raise iron stores and improve aerobic performance in menstruating women with low ferritin.

  Recruiting Lindenwood University · Saint Charles, Missouri · NCT07546591

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.